September 19, 2025
theresa-g-avatar-small - light bg
Morning Rounds Writer and Reporter
Good morning and happy Friday. I hope you've got a restful weekend ahead. There's just one more day of this ACIP meeting to get through before we're there. 

meetings

ACIP day one, recapped

A gloved hand holds up a syringe with a hepatitis B vaccine

ROBYN BECK/AFP via Getty Images

The day began with confrontation. At the start of the Advisory Committee on Immunization Practice’s two-day meeting, committee chair Martin Kulldorff challenged nine former heads of the CDC to “a live public debate with me concerning vaccines.” If they refuse, he said, don’t trust them. STAT’s Matt Herper and Chelsea Cirruzzo wrote about the opening salvo, characterized by some as political theater. 

From there, panelists considered recommendations related to shots on the pediatric vaccine schedule. (Covid-19 shots are on the agenda for today, so buckle up for that.) The committee voted 8-3 (with one member abstaining) to recommend that children under four receive the measles, mumps, rubella vaccine and varicella vaccine separately, rather than receiving the combined MMRV vaccine. The CDC has already said that it prefers this first dose be given as two separate shots, as there is a very small but higher seizure risk when giving the first dose combined.

The panel also discussed whether to recommend delaying the first hepatitis B vaccine shot, currently given at birth, by at least a month for babies born to mothers that test negative for the virus. During the meeting, the committee was repeatedly asked by observers why they had decided to revisit the long-standing practice of a birth dose. The analyses presented by CDC staffers showed that the hepatitis B vaccine is safe and effective. Still, several members questioned that data. Read more from a team of STAT reporters on how it all unfolded, and keep your eyes out for more coverage of the hepatitis B vote today.


one big number

31 of 38

That’s how many confirmed Ebola cases have resulted in death in southern Congo, where authorities have been fighting a new outbreak of the deadly virus since earlier in the month. The casualty rate has nearly doubled since last week. A vaccination campaign began in the affected region on Sunday. Read more.  


to whom it may concern

The FDA comes for GLP-1 compounding

Hundreds of telehealth companies, concierge medical practices, and medical spas have over the last few years built huge businesses offering compounded versions of popular GLP-1 obesity drugs while branded versions were in shortage. In nearly 60 warning letters sent last week and published on Tuesday, the FDA took these health providers and companies to task for false and misleading claims about the compounded products they market. 

“This is good that FDA is doing this,” said Reshma Ramachandran, a physician who recently coauthored a study that found 37% of websites marketing compounded GLP-1s stated or implied that the drugs were FDA-approved. But could the letters spur real change? Read more from STAT’s Katie Palmer to see what experts are expecting to come from this, and what they’re still waiting for.



to whom else it may concern 

What a protest letter reveals about the mood at federal agencies

Nearly 900 federal workers from more than 50 agencies signed onto a letter, published yesterday, condemning the Trump administration for executive overreach and urging Congress to step in. It’s the most recent in a series of letters from folks at different agencies criticizing the Trump administration for abandoning the agencies’ core missions. Some organizers initially hoped there would be thousands of signatures by the time the letter was publicly released, but the momentum wasn’t quite there as people weighed the risk to their jobs — and increasingly, their safety.

“Folks are feeling very unsafe not just in terms of their jobs, but also being in public around any kind of contentious issue just given the tense climate,” said Jenna Norton, one of the organizers. It’s not a theoretical concern. After Environmental Protection Agency employees signed a “declaration of dissent” criticizing the Trump administration’s leadership, dozens of employees were suspended without pay and several were fired. Read more from STAT’s Angus Chen and Anil Oza about the latest action and what it means.


policy

HHS wants to close a Miami organ transplant agency

HHS is moving to decertify a major organ procurement organization run out of the University of Miami Health System due to unsafe practices, poor training, understaffing, and administrative errors, agency leadership announced yesterday. The group, Life Alliance Organ Recovery Agency, can appeal the decision. But if it goes through, it will mark the first time that any OPO has been decertified. The agency is one of four organizations coordinating transplants in Florida.

The move comes about two months after an explosive federal report revealed that a Kentucky OPO ignored signs of life in patients when authorizing attempted organ removals. (Kennedy warned then that he would decertify the Kentucky group if they didn’t comply with corrective action requirements, but no updates have been provided.) HHS is trumpeting the move to decertify the Florida program as part of a reform initiative for the organ transplant system announced with the initial report in July. Read more.


mental health

New federal data on deaths by suicide

In 2023, the overall suicide rate in the U.S. was about 14 per 100,000 people, according to new analysis in the CDC’s Morbidity and Mortality Weekly Report. That’s consistent with the past five years or so, but there were changes within different racial groups. 

Suicide rates among Black people in the U.S. rose 25% from 2018 to 2023, while rates among Hispanic people rose 10%. Suicide rates among white people decreased 3% in that same time. Suicide rates were continuously highest among American Indian or Alaska Native people — but those rates did decline 15% between 2021 and 2023. 

The findings add to previously reported data on the early days of the pandemic, which found a similar increase in suicide rates among young people who weren’t white


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • What it’s like raising trans kids in Trump’s backyard, The 19th

  • I’m a doctor — and I introduce myself by my first name, STAT
  • Ticks are migrating, raising disease risks if they can't be tracked quickly enough, KFF Health News
  • Opinion: Why pharma companies are suddenly pausing investment in the U.K., STAT